The editor of the New England Journal of Medicine says three large drug companies have made a mockery of efforts to create transparency in clinical trials.
Journal editors last year pushed for drug companies to register trials in a public database, disclosing what each study is supposed to evaluate, how many patients will be studied, and who is funding the study.
Dr. Jeffrey Drazen says that Pfizer, GlaxoSmithKline and Merck are giving "nonsense details" and not providing enough useful information when they do register trials at www.clinicaltrials.gov.